✦ LIBER ✦

Risk factors for orofacial and limbtruncal tardive dyskinesia in older patients: a prospective longitudinal study

✍ Scribed by J. S. Paulsen; M. P. Caligiuri; B. Palmer; L. A. McAdams; D. V. Jeste

Publisher: Springer
Year: 1996
Tongue: English
Weight: 964 KB
Volume: 123
Category: Article
ISSN: 0033-3158
DOI: 10.1007/bf02246639

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence and risk factors for tardive

Prevalence and risk factors for tardive dyskinesia: a study in an Italian population of chronic schizophrenics

✍ A. C. Altamura; R. Cavallaro; M. G. Regazzetti 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 405 KB

Risk factors at pretreatment predicting

Risk factors at pretreatment predicting treatment-induced nausea and vomiting in Australian cancer patients: a prospective, longitudinal, observational study

✍ Carlo Pirri; Paul Katris; James Trotter; Evan Bayliss; Robert Bennett; Peter Dru 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 219 KB

Risk factors for progressive cartilage l

Risk factors for progressive cartilage loss in the knee : A longitudinal magnetic resonance imaging study in forty-three patients

✍ Sandip Biswal; Trevor Hastie; Thomas P. Andriacchi; Gabrielle A. Bergman; Michae 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 541 KB

## Abstract ## Objective To evaluate the rate of progression of cartilage loss in the knee joint using magnetic resonance imaging (MRI) and to evaluate potential risk factors for more rapid cartilage loss. ## Methods We evaluated baseline and followup MRIs of the knees in 43 patients (minimum ti

Systemic lupus erythematosus in a multie

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients

✍ Jaime Calvo-Alén; Sergio M. A. Toloza; Mónica Fernández; Holly M. Bastian; Barri 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

## Abstract ## Objective Venous thrombosis is a relatively frequent and serious complication in systemic lupus erythematosus (SLE) that has been associated with the presence of antiphospholipid antibodies (aPL). However, venous thrombotic events can also be seen in patients without aPL, and only a